To The Moon

$Rocket Lab USA, Inc.(RKLB)$ $AST SpaceMobile, Inc.(ASTS)$  $SpaceX(SPCX)$  🚀 $RKLB Q2 2026 earnings: Record growth, but Neutron is the real trade 🚀

Rocket Lab just delivered the kind of quarter most growth investors dream about:

🟢 EPS: -$0.08 | Est. -$0.08

🟢 REV: $234.07M | Est. $230.94M

🟢 Revenue: +62% YoY

🟢 Backlog: $2.36B | +137% YoY

🟢 New post-quarter contracts: >$1B

And yet $RKLB is getting hit roughly 9%.

Why?

Because this earnings report exposed something important about the valuation: investors are no longer debating whether Rocket Lab can grow. They are debating how quickly Neutron can turn that growth into a much larger launch opportunity.

🎯 The Neutron problem

This is the key takeaway for me.

Rocket Lab continues to make substantial progress on Neutron, but management acknowledged that the window for a 2026 launch is narrowing.

That matters because Neutron is not simply another product launch.

It is the bridge between Rocket Lab being a rapidly growing space-systems company and becoming a serious medium-lift launch competitor capable of attacking the much larger constellation, national-security and exploration markets.

The market is effectively saying:

“Show me Neutron.”

And that explains why a 62% revenue growth print and 137% backlog explosion were not enough to save the stock today.

🐂 The bull case

📈 Revenue momentum

Q2 revenue reached a record $234M, up 62% YoY, comfortably above guidance.

Even more impressive, product revenue reached approximately $181M, highlighting just how rapidly Space Systems is becoming the economic engine.

📚 Backlog is exploding

Backlog reached $2.36B, up 137% YoY.

Then Rocket Lab added more than $1B of additional contracts after quarter-end.

That provides extraordinary visibility and shows that demand is not the problem.

Execution capacity is.

🛡️ National security is becoming a moat

Rocket Lab’s Space Systems business continues moving up the value chain, with major government and defence awards reinforcing its transition from launch provider toward a vertically integrated space prime.

The $397M SB-AMTI award is particularly significant because it demonstrates Rocket Lab can compete for missions historically dominated by much larger aerospace contractors.

🚀 Neutron remains the multiplier

This is where the asymmetric upside sits.

Electron has established Rocket Lab’s credibility.

Space Systems has established scale.

Neutron could unlock the next leg of the TAM.

If Rocket Lab can successfully achieve first flight and then establish reliable cadence, the company moves into a substantially larger launch market.

That is why the market is so sensitive to every Neutron update.

🐻 The bear case

⚠️ The 2026 window is narrowing

This is the headline risk.

Every quarter of delay pushes out the revenue opportunity associated with Neutron and increases the amount of capital required before the vehicle contributes economically.

For a company trading on future potential, timing matters almost as much as the eventual outcome.

📉 Margins are going the wrong way

Q2 non-GAAP gross margin was approximately 41.5%, but Q3 guidance drops to 35%–37%.

Adjusted EBITDA also swings from an $8.8M loss in Q2 to a guided $17M–$23M loss in Q3.

That tells me Rocket Lab is deliberately prioritising expansion, capacity and strategic positioning over near-term profitability.

That can work brilliantly.

But only if the investments generate the expected returns.

💰 Iridium changes the equation

The proposed $8B acquisition of Iridium is arguably the most transformational part of the entire thesis.

It would give Rocket Lab an established satellite communications business with recurring revenue, a global network, spectrum assets and millions of subscribers.

But I would not treat this as “free growth”.

The transaction is expected to require substantial financing, including a $3.6B bridge facility, while completion is targeted for mid-2027 and remains subject to shareholder and regulatory approvals.

That creates another major question for investors:

Can Rocket Lab simultaneously fund Iridium, scale Space Systems, absorb acquisitions and finance Neutron without putting too much pressure on shareholders or the balance sheet?

That is the part of the story I’m watching very closely.

⚖️ My verdict: 🟢 Bullish, but more conditional

I remain bullish on $RKLB.

But I think today’s reaction is rational.

The underlying business is accelerating at an extraordinary rate. Revenue is compounding, backlog is exploding, national-security exposure is expanding and the company is moving far beyond being “just a rocket company”.

However, the valuation increasingly requires execution on Neutron.

For me, the thesis now has three critical milestones:

1️⃣ Neutron first flight

2️⃣ Neutron transition from demonstration to repeatable cadence

3️⃣ Successful integration and financing of the Iridium transaction

If Rocket Lab executes on all three, today’s pullback could eventually look like a speed bump.

If Neutron continues slipping while margins compress and acquisition-related financing increases dilution or leverage, the market could remain unforgiving.

That is the fascinating part of $RKLB.

The market isn’t questioning whether Rocket Lab can grow.

It is questioning whether management can execute several transformational moves simultaneously.

👉❓ Do you think today’s selloff is an overreaction to the narrowing Neutron timeline, or is the market correctly repricing $RKLB for the execution risk?

I’m watching the rocket, the backlog and the balance sheet.

Because with $RKLB, the next launch isn’t just another mission.

It could be the next valuation catalyst. 🚀📈

📢 Don’t miss out! Like, Repost, Comment and Follow me for exclusive setups, cutting-edge trends and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market, share ideas and stack those gains together! 🍀

Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀